Salarius Pharmaceuticals Inc. share price logo

Salarius Pharmaceuticals Inc. Share Price

NASDAQ: SLRX

Small Cap

$5.55

-0.14

(-2.46%)

as on

Salarius Pharmaceuticals Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $5.42
    $5.8
    downward going graph

    2.34%

    Downside

    4.50%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.5
    $108
    downward going graph

    18.92%

    Downside

    1845.95%

    Upside

    downward going graph

Salarius Pharmaceuticals Inc. share price movements today

Previous Close
$5.69
Open
$5.51
Volume
348.6K
Day's Low - High
$5.42 - $5.8
52 Week Low - High
$4.5 - $108

Salarius Pharmaceuticals Inc. Historical Returns

1 Month Return
-16.84 %
3 Month Return
-65.71 %
1 Year Return
-79.08 %
3 Year Return
-99.26 %
5 Year Return
-99.79 %

Salarius Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Salarius Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-5.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

3044800.00%

Salarius Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Salarius Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$2.9M-99.79%NA0.00%
BUY$60.5B241.54%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Salarius Pharmaceuticals Inc. Stock including INR - Dollar returns

The Salarius Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Salarius Pharmaceuticals Inc. investment value today

Current value as on today

₹25,857

Returns

₹74,143

(-74.14%)

Returns from Salarius Pharmaceuticals Inc. Stock

₹79,096 (-79.1%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Salarius Pharmaceuticals Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Salarius Pharmaceuticals Inc.. Average target price of $26

Salarius Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Salarius Pharmaceuticals Inc..

What analysts predicted

78.65%UPSIDE

Target Price

$26

Current Price

$5.55

Analyzed by

6 Analysts

Target

$26.00

Salarius Pharmaceuticals Inc. target price $26, a slight upside of 78.65% compared to current price of $5.55. According to 6 analysts rating.

Salarius Pharmaceuticals Inc. Stock's Interest Amongst Investors

Search interest for Salarius Pharmaceuticals Inc. Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Salarius Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-5
-3
-2
0
-1
-1
-1
-1
-1
0
EBITDA
-5
-3
-2
0
-1
-1
-1
-1
-1
0
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-3
-2
0
-1
-1
0
-1
-1
0
Income Tax Expense
0
0
0
0
0
0
-
-
-
-
Net Income
-5
-3
-2
0
-1
-1
0
-1
-1
0
Net Profit Margin
0.00%
0.00%
0.00%
-4928.44%
0.00%
0.00%
0.00%
-33075.76%
0.00%
0.00%

Salarius Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
1
0
3
5
1
-
-
-
Gross Profit
0
0
0
3
5
1
0
0
0
Operating Income
-39
-34
-22
-8
-7
-12
-22
-12
-5
EBITDA
-39
-34
-21
-8
-7
-12
-31
0
-5
Interest Expense
-
-
-
-
0
0
0
-
-
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-39
-34
-21
-6
-7
-12
-31
-12
-5
Income Tax Expense
0
0
0
-1
0
0
0
-12
-5
Net Income
-39
-34
-21
-6
-7
-12
-31
-12
-5
Net Profit Margin
-3906.33%
-2700.71%
-2615.99%
-200.18%
-140.49%
-693.84%
0.00%
0.00%
0.00%

Salarius Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-3
-2
0
-1
-1
0
-1
-1
0
Operating Cash Flow
-4
-3
-1
-1
-1
-1
0
-1
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
6
0
0
0
0
1
0
0
0
Change in Cash
2
-3
-1
-1
-1
0
0
0
-1

Salarius Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-39
-34
-21
-6
-7
-12
-31
-12
-5
Operating Cash Flow
-32
-27
-23
-11
-10
-10
-17
-12
-4
Investing Cash Flow
-12
24
14
5
0
-1
-1
-
-
Financing Cash Flow
0
0
0
3
17
28
1
6
1
Change in Cash
-44
-3
-9
-2
7
18
-17
-6
-3

Global Institutional Holdings in Salarius Pharmaceuticals Inc.

Funds
Holdings
UBS Group AG
1.59%
TWO SIGMA SECURITIES, LLC
0.72%
Geode Capital Management, LLC
0.54%
Tower Research Capital LLC
0.16%
Advisor Group Holdings, Inc.
0.01%

Insights on Salarius Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 210.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 147.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SLRX stock has moved down by -16.8%

About Salarius Pharmaceuticals Inc.

salarius is an oncology based biotechnology company developing targeted treatments for patients who need them the most.
OrganisationSalarius Pharmaceuticals Inc.
Headquarters2450 Holcombe Blvd., Houston, TX, United States, 77021
IndustryHealth Technology
CEOMr. Mark J. Rosenblum CPA
E-voting on sharesClick here to vote

Key Management of Salarius Pharmaceuticals Inc.

Name

Title

Mr. Mark J. Rosenblum CPA

Acting CEO, Executive VP of Finance & CFO

FAQs

What is Salarius Pharmaceuticals Inc. share price today?

Salarius Pharmaceuticals Inc. share price today is $5.55 as on at the close of the market. Salarius Pharmaceuticals Inc. share today touched a day high of $5.8 and a low of $5.42.

What is the 52 week high and 52 week low for Salarius Pharmaceuticals Inc. share?

Salarius Pharmaceuticals Inc. share touched a 52 week high of $108 on and a 52 week low of $4.5 on . Salarius Pharmaceuticals Inc. stock price today i.e. is closed at $5.55,which is 94.86% down from its 52 week high and 23.33% up from its 52 week low.

What is Salarius Pharmaceuticals Inc.'s market capitalisation today?

Salarius Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Salarius Pharmaceuticals Inc. Stock (SLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Salarius Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Salarius Pharmaceuticals Inc. Shares that will get you 0.2703 shares as per Salarius Pharmaceuticals Inc. share price of $5.55 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Salarius Pharmaceuticals Inc. Stock (SLRX) from India?

Indian investors can start investing in Salarius Pharmaceuticals Inc. (SLRX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Salarius Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Salarius Pharmaceuticals Inc. share’s latest price of $5.55 as on September 18, 2025 at 1:29 am IST, you will get 1.8018 shares of Salarius Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Salarius Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Salarius Pharmaceuticals Inc. stock has given -99.79% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?